ALICE'S ARC — grant history

Registered charity 1164253 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines

Latest income

£788k

Grants listed (FY2024)

Listed grants total

£618k

Accounts grants total

£618k

listed grants reconcile with the accounts totalextracted from its FY2024 accounts

Application guidance — from the funder’s own website

How to apply: The website does not provide a process for unsolicited applications. It states that a 'Request for Applications (RFA) in conjunction with SBF EPICC will lead to a $750K RMS research grant', indicating funding is awarded through specific collaborative partnerships rather than open calls.

Summarised from www.alicesarc.org · www.alicesarc.org/alices-arc-us-inc-st-baldricks-epicc-team-awards-grant-of-750k-for-rms-research/ on 16/08/2026. Always check the funder’s site before applying.

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded

Education/training (1 grantee)
The Advancement Of Health Or Saving Of Lives (1 grantee)

Where grantees operate

Northern Ireland (1 grantee)
Scotland (1 grantee)
Throughout England And Wales (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

Recipient	Year	Amount	Purpose
Alice’s Arc US Inc	FY2024	£250k	Research grant
The Institute of Cancer Research	FY2024	£205k	Research grant
The University of Birmingham	FY2024	£76k	Research grant
European paediatric Soft tissue Sarcoma Group (EpSSG)	FY2024	£71k	Research grant
University of York	FY2024	£17k	Research grant
The Institute of Cancer Research	FY2023	£547k	£339k to kickstart the first year of the project designed to unravel the mystery of the causes of cell changes leading to relapsed and refractory rhabdomyosarcoma. £45k for the second year of a work package relating to maturation targets and resistance models. £113k towards year two of the project investigating the MYOD1 L122R mutation in fusion negative disease.
University College London	FY2023	£134k	PostDoc to take information from Wellcome Sanger’s single cell analysis forward to develop a CAR T-cell treatment for rhabdomyosarcoma.
The University of Birmingham	FY2023	£48k	Year two of a research project designed to investigate fusion negative rhabdomyosarcoma with RAS pathway alterations focusing on DNA repair and replication stress.
University of York	FY2023	£17k	Payment for year one of Living REFoRMS, a project designed to aid families decision-making at the point of relapsed/refractory rhabdomyosarcoma by creating an online ‘dynamic’ resource.
Wellcome Sanger	FY2023	£5k	Work relating to the immune environment scRNAseq which includes re-agents, library making and sequencing for the project entitled ‘Identification and evaluation of foetal immune targets in rhabdomyosarcoma’.
University of Ulster	FY2023	£4k	Project involved two parent focus groups in order to discuss pathways to improve the sleep of children with life limiting conditions.
Teenage Cancer Trust	FY2023	£300	Not specified in detail, listed in Note 3.
Institute of Cancer Research	FY2022	£218k	Research into rhabdomyosarcoma
University of Birmingham	FY2022	£81k	Research into rhabdomyosarcoma
Wellcome Sanger Institute	FY2022	£57k	Research into rhabdomyosarcoma
European Paediatric Soft tissue sarcoma Study Group (EpSSG)	FY2022	£33k	Research support/operational management
University of Ulster	FY2022	£4k	Research into sleep of children with life limiting conditions

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 618070 vs reference 618071 (0.0% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.